Global Dental Surgical Equipment Market Expands on Rising Oral Disease Burden According to a newly published market research report by 24LifeSciences, global dental surgical equipment market was valued at USD 5,808 million in 2024 and is projected to reach USD 7,727 million by 2031, growing at a compound annual growth rate (CAGR) of 4.3% during the forecast period 2025-2031. Dental surgical equipment comprises the specialized instruments and devices used for the diagnosis, surgical intervention, and treatment of oral diseases and conditions. This includes a wide array of products from diagnostic imaging systems and lasers to therapeutic instruments, delivery systems, and surgical handpieces. These tools are essential for procedures ranging from routine tooth extractions to complex dental implantology and maxillofacial surgeries, forming the backbone of modern oral healthcare delivery. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9104/dental-surgical-equipment-market

What Is the Future of the Dental Electrosurgical Generators Market? Growth Insights According to a newly published market research report by 24LifeSciences, global dental surgery electrosurgical generators market was valued at USD 285 million in 2024 and is projected to reach USD 425 million by 2032, growing at a compound annual growth rate (CAGR) of 5.1% during the forecast period. Dental surgery electrosurgical generators are advanced medical devices that produce high-frequency electrical currents for cutting, coagulating, desiccating, and fulgurating tissues during dental procedures. These systems are indispensable in modern dentistry, enabling precise soft tissue management with minimized bleeding and enhanced surgical visibility. Available in monopolar and bipolar configurations, they are essential tools for procedures ranging from gingivectomies to implantology, supporting both routine and complex oral surgeries. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/10136/dental-surgery-electrosurgical-generators-market

Tissue Sealants and Adhesives Market to Reach USD 7.26 Billion by 2032 | Trends & Forecast According to a newly published market research report by 24LifeSciences, global tissue sealants and tissue adhesive market was valued at USD 4.12 billion in 2024 and is projected to reach USD 7.26 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.4% during the forecast period 2025–2032. Tissue sealants and adhesives are advanced biomaterials used to achieve hemostasis and approximate wound edges, effectively replacing or supplementing traditional sutures and staples. These products function by creating a barrier or bond that promotes natural healing while preventing fluid or air leakage from tissues and organs. Major product categories include fibrin sealants, collagen-based sealants, synthetic adhesives like cyanoacrylates, and albumin-based glues, each designed for specific surgical applications across cardiovascular, orthopedic, and general surgery. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/10358/tissue-sealants-and-tissue-adhesive-market

FibroTouch Devices Market Size to Reach USD 220 Million by 2032 | Growth Insights Global FibroTouch Devices market is undergoing steady expansion as healthcare systems increasingly prioritize non-invasive diagnostics for liver disease management. Valued at USD 120 million in 2024, the market is projected to grow from USD 132 million in 2025 to USD 220 million by 2032, registering a CAGR of 7.8% during the forecast period. This growth reflects a structural shift away from invasive liver biopsies toward faster, safer, and more patient-friendly elastography-based solutions that deliver real-time clinical insights. The FibroTouch Devices market is gaining prominence across hospitals, diagnostic centers, and specialty clinics as chronic liver conditions such as NAFLD, viral hepatitis, and alcoholic liver disease continue to rise globally. Increasing disease awareness, early screening initiatives, and technological refinements are positioning FibroTouch as a core diagnostic modality in modern hepatology workflows. Access the market report https://www.24lifesciences.com/fibrotouch-devices-market-9969

Tardive Dyskinesia Treatment Market Size to Reach USD 1.3 Billion by 2032 | Growth Insights Global Tardive Dyskinesia Treatment market is undergoing a notable transformation as healthcare systems prioritize early diagnosis, neurological specialization, and precision pharmacotherapy. Valued at USD 643.5 million in 2024, the market is projected to grow from USD 720.6 million in 2025 to USD 1.3 billion by 2032, expanding at a CAGR of 9.2% during the forecast period. Rising awareness of movement disorders, increased use of long-term antipsychotic therapies, and the growing adoption of FDA-approved VMAT2 inhibitors are central to this sustained growth trajectory. Access the market report https://www.24lifesciences.com/tardive-dyskinesia-treatment-market-10341

Oral Flat Panel Detector Market Size to Reach USD 560 Million by 2032 | Dental Imaging Trends Global oral flat panel detector market is witnessing steady expansion as digital dentistry becomes a core component of modern oral healthcare. Valued at approximately USD 320 million in 2024, the market is expected to grow from USD 345 million in 2025 to USD 560 million by 2032, registering a compound annual growth rate (CAGR) of around 7.2% during the forecast period. This growth is driven by the rapid replacement of analog imaging systems, rising demand for high-resolution diagnostics, and increasing adoption of advanced dental technologies across clinical settings. Access the complete report https://www.24lifesciences.com/oral-flat-panel-detector-market-9920

Facial Paralysis Treatment Market Size to Reach USD 3.4 Billion by 2032 | Growth Forecasts & Insights Global facial paralysis treatment market is witnessing strong momentum as healthcare systems increasingly prioritize neurological rehabilitation, early intervention, and functional recovery. Valued at USD 1.8 billion in 2024, the market is expected to expand from USD 1.95 billion in 2025 to USD 3.4 billion by 2032, registering a robust CAGR of 7.2% during the forecast period. This growth reflects rising disease awareness, advances in medical therapies and surgical techniques, and growing demand for comprehensive, multidisciplinary care models. Access the complete report https://www.24lifesciences.com/facial-paralysis-treatment-market-9209

Circulating Tumor Cell Detector Market Size to Reach USD 15.1 Billion by 2032 | Growth Insights Global circulating tumor cell detector market is undergoing a pivotal transformation as oncology care shifts toward non-invasive, precision-driven diagnostics. Valued at USD 7.2 billion in 2024, the market is projected to grow from USD 7.9 billion in 2025 to USD 15.1 billion by 2032, expanding at a CAGR of 9.4% during the forecast period. This sustained growth reflects the rising global cancer burden and the increasing clinical reliance on liquid biopsy technologies to guide diagnosis, prognosis, and treatment monitoring. Access the complete report https://www.24lifesciences.com/circulating-tumor-cell-detector-market-10059

Multiple Sclerosis Treatment Market Size to Reach USD 19.1 Billion by 2032 | Growth Global multiple sclerosis treatment market is undergoing steady clinical and commercial evolution as healthcare systems prioritize early diagnosis, disease modification, and long-term neurological care. Valued at USD 16.5 billion in 2024, the market is projected to grow from USD 16.9 billion in 2025 to USD 19.1 billion by 2032, registering a CAGR of 2.2% over the forecast period. This measured growth reflects the maturity of established therapies alongside continuous innovation in high-efficacy disease-modifying treatments (DMTs). Access the complete report https://www.24lifesciences.com/multiple-sclerosis-treatment-market-9542

Peptide and Heparin Market Size to Reach USD 58.9 Billion by 2031 | Growth Insights Global peptide and heparin market is undergoing steady and strategic expansion, supported by rising demand for advanced biologic therapies and critical anticoagulation treatments. Valued at USD 42.5 billion in 2024, the market is projected to reach USD 58.9 billion by 2031, growing at a CAGR of 4.8% during the forecast period. This growth reflects the increasing clinical reliance on peptide-based drugs and heparin across cardiovascular care, oncology, and metabolic disorder management worldwide. Access the complete report https://www.24lifesciences.com/peptide-and-heparin-market-9010

What Is the Future of the Global Glycoprotein Market? Growth Forecasts & Insights (2025–2031) Global glycoprotein market is witnessing steady and resilient growth as glycosylated proteins continue to play a critical role in modern biomedical research and advanced biologic therapies. Valued at USD 462 million in 2024, the market is projected to reach USD 587 million by 2031, expanding at a compound annual growth rate (CAGR) of 3.6% over the forecast period. This growth trajectory reflects sustained investments in biologics, rising demand for high-precision therapeutic agents, and the expanding importance of glycosylation in drug safety, efficacy, and stability. Access the complete report https://www.24lifesciences.com/glycoprotein-market-6869

What Is the Future of the Global Glycoprotein Market? Growth Forecasts & Insights (2025–2031) Global glycoprotein market is witnessing steady and resilient growth as glycosylated proteins continue to play a critical role in modern biomedical research and advanced biologic therapies. Valued at USD 462 million in 2024, the market is projected to reach USD 587 million by 2031, expanding at a compound annual growth rate (CAGR) of 3.6% over the forecast period. This growth trajectory reflects sustained investments in biologics, rising demand for high-precision therapeutic agents, and the expanding importance of glycosylation in drug safety, efficacy, and stability. Access the complete report https://www.24lifesciences.com/glycoprotein-market-6869

Global Rapid Diagnostics Market Expands as Point-of-Care Testing Becomes Central to Healthcare Global rapid diagnostics market is witnessing robust expansion as healthcare systems worldwide prioritize early detection, faster clinical decisions, and decentralized testing models. Valued at approximately USD 46.7 billion in 2024, the market is projected to grow from USD 50.1 billion in 2025 to around USD 76.4 billion by 2032, registering a CAGR of 6.2% during the forecast period. This growth reflects the increasing reliance on rapid diagnostic solutions across hospitals, clinics, and community settings to improve patient outcomes and optimize healthcare efficiency. Access the complete report https://www.24lifesciences.com/rapid-diagnostics-market-9182

What Is the Future of the Amoxicillin Clavulanate Potassium API Market? Growth Forecasts & Insights (2025–2031) The global Amoxicillin Clavulanate Potassium API market is demonstrating steady expansion as healthcare systems continue to rely on broad-spectrum antibiotics to combat bacterial infections and antimicrobial resistance. Valued at USD 275 million in 2024, the market is projected to reach USD 415 million by 2031, growing at a compound annual growth rate (CAGR) of 6.1% during the forecast period. This growth reflects sustained global demand for high-quality antibiotic active pharmaceutical ingredients (APIs), alongside evolving formulation strategies designed to improve efficacy against resistant pathogens. Access the complete report https://www.24lifesciences.com/amoxicillin-clavulanate-potassium-api-market-8769

Global GIST Market Shows Steady Expansion Driven by Targeted Oncology Therapies Global gastrointestinal stromal tumor (GIST) market is demonstrating sustained growth as advances in molecular oncology and targeted therapies continue to redefine treatment standards. Valued at USD 1.08 billion in 2024, the market is projected to grow from USD 1.15 billion in 2025 to USD 1.76 billion by 2032, expanding at a CAGR of 5.8% during the forecast period. This upward trajectory reflects increasing diagnostic accuracy, wider access to tyrosine kinase inhibitors, and a growing emphasis on personalized cancer care worldwide. Access the complete report https://www.24lifesciences.com/gastrointestinal-stromal-tumor-market-9149

Global Paraneoplastic Syndrome Treatment Market Poised for Steady Expansion Global paraneoplastic syndrome treatment market is gaining strategic importance within the broader rare disease and oncology care landscape, driven by rising cancer prevalence and improved clinical recognition of autoimmune neurological disorders. Valued at USD 1.28 billion in 2024, the market is projected to grow from USD 1.37 billion in 2025 to USD 2.16 billion by 2031, registering a compound annual growth rate (CAGR) of 6.7% during the forecast period. This growth reflects increasing demand for early intervention, immunotherapy-driven treatment protocols, and multidisciplinary care models capable of managing complex paraneoplastic manifestations. Access the complete report https://www.24lifesciences.com/paraneoplastic-syndrome-treatment-market-9070

Global Nanomedicine Market Enters a High-Growth Phase Driven by Precision Drug Delivery Global nanomedicine market is steadily advancing as healthcare systems increasingly adopt precision-based therapeutic and diagnostic solutions. Valued at USD 164 million in 2024, the market is projected to grow from USD 175 million in 2025 to USD 260 million by 2032, registering a CAGR of 6.9% over the forecast period. This growth trajectory highlights the expanding clinical acceptance of nanoscale technologies designed to enhance treatment efficacy, reduce toxicity, and improve patient outcomes across complex disease areas. Access the complete report https://www.24lifesciences.com/nanomedicine-market-9129

What Is the Future of the PET Equipment Market? Growth Forecasts & Insights Global Positron Emission Tomography (PET) equipment market is undergoing accelerated expansion as healthcare systems worldwide prioritize early diagnosis, precision medicine, and advanced imaging technologies. Valued at USD 3.52 billion in 2024, the market is projected to reach USD 6.21 billion by 2031, registering a robust CAGR of 9.7% over the forecast period. This growth reflects rising demand for high-resolution functional imaging across oncology, cardiology, neurology, and clinical research, positioning PET technology as a cornerstone of modern diagnostic care. Access the complete report https://www.24lifesciences.com/positron-emission-tomography-pet-equipment-market-market-5988

Global Dental Biomaterial Market Outlook Accelerates with Restorative and Bioactive Innovations Global dental biomaterial market is undergoing steady and technology-driven expansion, supported by rising oral healthcare demand, innovation in material science, and the growing emphasis on long-term clinical outcomes. Valued at USD 7.89 billion in 2024, the market is projected to reach USD 10.82 billion by 2031, growing at a CAGR of 4.7% during the forecast period. This growth reflects the convergence of restorative dentistry, regenerative medicine, and advanced biocompatible materials across global healthcare systems. Access the complete report https://www.24lifesciences.com/dental-biomaterial-market-8642

What Is the Future of the Oral Cancer Treatment Market? Growth Forecasts & Insights to 2032 Global oral cancer treatment market is undergoing significant transformation as healthcare systems adopt more advanced therapeutic approaches, precision oncology, and early detection strategies. Valued at USD 2,410 million in 2024, the market is projected to increase from USD 2,518 million in 2025 to USD 3,220 million by 2032, reflecting a 4.3% CAGR. Growth is strongly driven by rising cancer prevalence, expanding geriatric populations, technological progress in oncology, and a robust shift toward targeted and immunotherapy-based treatment pathways. Access the complete report https://www.24lifesciences.com/oral-cancer-treatment-market-9564